Molecular landscape of head and neck cancers – Therapeutic implications
International Journal of Molecular and Immuno Oncology · 20.03.2026 · 11 · 27-30
DOI: 10.25259/ijmio_40_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular and Immuno Oncology, online erschienen am 20.03.2026. Verfasst von B. Minu Chandra Muddabhaktuni. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Head and neck cancers – especially head and neck squamous cell carcinoma – develop through a network of molecular aberrations, including faulty DNA repair, deregulated cell-cycle control, impaired apoptosis, and disrupted signaling for proliferation, invasion, and angiogenesis. These include frequent loss or mutation of tumor suppressors (e.g., tumor protein p53 [TP53] and cyclin-dependent kinase inhibitor 2A [CDKN2A]) and activation or amplification of oncogenes (e.g., phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [PIK3CA] and cyclin D1 [CCND1]), leading to abnormal growth and survival of malignant cells. Recognizing these molecular mechanisms paves the way for targeted strategies – such as inhibitors of DNA repair pathways, cell-cycle regulators, epigenetic modulators, or immune-based therapies – offering more tailored and potentially effective treatments.
Zitieren
APA
Muddabhaktuni, B. M. C. (2026). Molecular landscape of head and neck cancers – Therapeutic implications. International Journal of Molecular and Immuno Oncology, 11, 27-30. https://doi.org/10.25259/ijmio_40_2025
Vancouver
Muddabhaktuni BMC. Molecular landscape of head and neck cancers – Therapeutic implications. International Journal of Molecular and Immuno Oncology. 2026;11:27-30. doi:10.25259/ijmio_40_2025
BibTeX
@article{Muddabhaktuni2026,
author = {Muddabhaktuni, B. Minu Chandra},
title = {Molecular landscape of head and neck cancers – Therapeutic implications},
journal = {International Journal of Molecular and Immuno Oncology},
year = {2026},
volume = {11},
pages = {27--30},
doi = {10.25259/ijmio_40_2025}
}
EUVIMED